CME Under Fire THOMAS SULLIVAN President Rockpointe Corporation March 6, 2009.

Slides:



Advertisements
Similar presentations
UCSF School of Medicine OCME Program Frequently Asked Questions Faculty Disclosure and Resolution of Conflict of Interest.
Advertisements

Introduction to Existing State Disclosure Laws and Regulations Summit on Disclosure, Transparency and Aggregate Spend For Drug, Device and Biotech Companies.
Professional Education Support Wyeth Pharmaceuticals Melinda Somasekhar, PhD.
CME 101 The Application Process Sponsored by the Office of Continuing Medical Education.
Pharmaceutical Compliance Current Trends: Hot Button Issues to Look at this Year in Sales, Marketing, Clinical, Medical Affairs and Government Pricing.
Hot Topics Commercial Support. What is Commercial Support? Commercial Support is financial or in- kind contributions given by a commercial interest which.
Managing Conflicts of Interest © ACCME.
Commercial support is defined as financial or in- kind contributions given by a commercial interest, which is used to pay all or part of the costs of a.
O PEN P AYMENTS An Explanation of Section 6002 of the Affordable Care Act Center for Program Integrity September, 2013 CMS Disclaimer: This information.
PDUFA and DTC Advertising Reviews Prior to Use Public Hearing February 16, 2007 Testimony of the Coalition for Healthcare Communication.
ACC and the Physician Payments Sunshine Act. Disclaimers Information provided in this presentation is for educational purposes only and should not be.
Pharmaceutical Compliance Congress: “State of the States” October 27, 2008 Janice G. Cunningham Jeffrey L. Handwerker.
1 Physician-Industry Transparency: The U.S. Physician Payment Sunshine Act.
2013 Joint KMS and MSMA CME Provider Conference. The Provider describes that its CME Committee sets the topics and educational goals of its CME activities.
A REVIEW FOR ALL PRESENTERS OF ASMBS-SPONSORED EDUCATIONAL ACTIVITIES ASMBS CME Policies, Procedures and Guidelines for Presenters.
Exploring the Accreditation Criterion 1-15 BEST PRACTICES.
# Operating Under the New Compliance Environment: Considerations for the Pharmaceutical Industry The Impact of the new Medicare Prescription Drug benefit.
Standards for Commercial Support: Standards to Ensure Independence in CME Activities SM Case Studies.
Open Payments Act AKA the ‘Sunshine Act’ Open Payments Act AKA the ‘Sunshine Act’ Public Postings of Physician Ownership, Investments, & Transfers of Value.
VCU School of Medicine Policy on Industry Relations Effective July 1, 2009.
Voluntary Codes MassMEDIC Meeting Are You Ready to Comply with Massachusetts’ New Pharmaceutical and Medical Device Code of Conduct Law? Linda D. Bentley,
© 2008 Foley Hoag LLP. All Rights Reserved. 1 The New Massachusetts Pharmaceutical & Medical Device Marketing Regulations How to Address and Overcome Likely.
New Staff Orientation: Industry Relations Emory School of Medicine Zainab R. Wurie, JD July 15, 2014.
CONFLICTS OF INTEREST PRESENTED BY THE UMMC OFFICE OF INTEGRITY AND COMPLIANCE.
(Name of Conference) Housekeeping Slides Welcome to the Name of Conference These are our daily announcements.
Jointly Sponsored by The Warren Alpert Medical School of Brown University and the New England Regional Chapter of the Society of Adolescent Health and.
Diane Benson, CTSM Global Events Manager GE Healthcare, Medical Diagnostics Kathy Clarke Managing Partner SageRock Advisors, LLC.
OPEN PAYMENTS UF College of Medicine Brown Bag July 23, 2013 Gary Wimsett, Jr., JD.
International Congress and Convention Association International Association Overview Ross Robinson 44 th ICCA Congress & Exhibition, Monday, November 7.
ACCREDITATION CRITERIA CONFLICT OF INTEREST CONTENT INTEGRITY.
Vendor Relations Policy. Why Is There A Policy? The Patient Protection and Affordable Care Act was signed into law March 23, The new law contains.
+ National and Institutional Guidelines on Conflict of Interest in Physician-Industry Relationships.
A Focus on CME and Grants Nancy Coddington, PhD Senior Director, Compliance Operations AstraZeneca Pharmaceuticals LP And Terry Hisey Deputy Managing Principal.
© 2013 The McGraw-Hill Companies, Inc. All rights reserved. Ch 8 Privacy Law and HIPAA.
WHAT STAKEHOLDERS NEED TO KNOW ABOUT THE CME/SUNSHINE ACT PROVISION OF THE ‘21 ST CENTURY CURES ACT’ JULY 14,
+ Role of Industry in Clinical Care, Research, and Education.
Partners Conflict of Interest Policy and Reporting October 11, 2012.
An Educational Session on HSC OP 10.27, Health Care Vendor Interactions April 20, 2009.
Copyright © Harvard Medical School. All Rights Reserved. Outside Activity Report: What Do I Need to Report?
Sara Lovell, CPCS Education Coordinator Providence Alaska Medical Center.
© 2004 Moses & Singer LLP HIPAA and Patient Privacy Issues Raised by the New Medicare Prescription Drug Program National Medicare Prescription Drug Congress.
“Commercial Interest” ● ‘exempt’ entities (per ACCME) ● ‘exempt’ entities (per ACCME) – 501-C non-profit organizations – Government organizations – Non-health.
ACCME at the International Pharmaceutical Compliance Summit Philadelphia March 2005.
What HIT Policy Changes Will Mean for MedTech October 22, 2004 Blair Childs Executive Vice President, Strategic Planning & Implementation.
Program Coordinator Medication Assistance Program Smilow Cancer Hospital at Yale New Haven Program Coordinator Medication Assistance Program Smilow Cancer.
Greg Levine. January 9, Enforcement Environment  Accelerating progression of off-label promotion cases – Not just “Big Pharma” – No “oncology exception”
Health Insurance Plans Intro to Health Science Unit One Lesson 5 Diversified Health Occupations pages.
New Hire HIPAA Orientation. HIPAA Overview HIPAA is an acronym that stands for the Health Insurance Portability and Accountability Act of HIPAA.
CME Process and Accreditation Criteria Objectives Explain Updated ACCME Accreditation Criteria Utilize the revised CME Planning Process to incorporate.
Joint Sponsorship American Association of Neurological Surgeons.
Disclosure of Financial Interest Policy. Medical Staff Policy Approved by the MEC’s Aimed at protecting the integrity of the LMHS Medical Staffs Requires.
Rheumatology Mastery in Ankylosing Spondylitis
Conflict of Interest, Commercial Support, Sponsorship
YOUR DISCLOSURE STATEMENT
Neurological Clinicopathologic Case Presentation
Contemporary Paradigms for Anticoagulant Reversal
Using ACCME’s Flowchart for the Identification and Resolution of Personal Conflicts of Interest A tutorial and flowchart to help you navigate the identification.
RxInsider Shannon Staton PharmD Candidate 2016
Pulmonary Rehabilitation and Readmission
The Physician Payments Sunshine Act
Heart Failure Management
Heart Failure Management
Can Mobile Technology Improve Outcomes?
CME and Consultants Compliance Roundtable
Disclosure of Faculty Conflict of Interest
Updates to the PhRMA Code on Interactions with Healthcare Professionals National Pharma Audioconference August 5, 2008.
“Ins & Outs of Eating Disorders”
ASMBS CME Policies, Procedures and Guidelines for Presenters
Research with Human Subjects
Neurology Grand Rounds
Presentation transcript:

CME Under Fire THOMAS SULLIVAN President Rockpointe Corporation March 6, 2009

Disclosure Rockpointe is a Science based Medical education company of 25 full time employees based in Columbia Maryland The Potomac Center for Medical Education is an ACCME accredited provider and receives financial grants from pharmaceutical and device manufactures I am committed to the free flow of ideas in CME and support the current ACCME Standards for Commercial Support™ Author of the website policy and medicine

What is CME Continuing medical education is important for: – Everyone in the field of medicine – Maintenance of competency/ licensure/board certification and hospital privileges – Uptake and the free flow of new information and practices – Translation of 150,000 journal articles published each month

Certified CME: Education produced by an accredited CME provider (not easy process) Complies with ACCME and other accrediting bodies standards Complies with federal compliance FDA/OIG guidance Content and delivery are independent of supporter (commercial) influence Complies with the AMA definition of CME Does not pay for participation, expenses, travel

Promotional Programs – Non CME Events/Courses Promotional Education – Pharma or Device company directed – Must stay on FDA Label – Reviewed by FDA and HHS IG’s office – Can not be altered by speakers – Designed to familiarize HCP’s with approved Drugs/ Devices and approved indications

Financial Support for CME 50% from private and public sources (subscriptions and attendee fees) 50% from grants including industry support Grants Represent $1.2 Billion of support (2007) Little support from public health, insurance companies, hospitals/health systems, universities

Regulatory Stakeholders in CME FDA HHS IG Congress States Attorney Generals State Legislatures Corporate Integrity Agreement s PhRMA -- AdvaMed CMS ACCME AMA, AAFP, ACPE, ANCC, State medical boards

How is CME regulated Federal and ACCME rules require that accredited providers: – Ensure that content is evidence based – Conflicts of Interest Disclosed and Resolved Speakers, staff, writers…. – Independence of Provider – On-Site Audits – Public Disclosure of Accreditation Status

Physicians Choice CME agenda is controlled by medicine Physicians are not paid to attend CME Participation is voluntary Physicians evaluate for Bias Varied CME opportunities: associations, journals, internet, meetings Quality wins out

Points to Consider with CME Commercial and Public Interest are not incompatible No evidence that commercial bias is harmful or wide spread Changes accelerated over last four years No viable alternative to funding Changes in regulations can have profound effect on patient care especially in rural and inner-city areas.

Revised PPSA 2009 and CME Reporting Payments over a cumulative value of $100 dollars. Requires Reporting of: –Honoraria, Food, Travel, Education –Compensation for serving as a faculty member or as a speaker for a continuing medical education program –Grant –Any other nature of payment or other transfer of value as defined by the secretary Collection of Medicare Billing Number

PPSA 2009 Language (Direct Payments) Provides a payment or other transfer of value to covered recipient (or to an entity or individual at the request of or designated on behalf of a covered recipient) Question – Does this exempt reporting information on CME participants and faculty and if so how?

PPSA 2009 Compensation as a CME Faculty or Speaker Local CME Providers – Must provide “timely” information to supporter on speaker compensation, travel and incidental expenses – Manufacturers will be hesitant to give small grants Multi Supported Programs – Would you apply the full payment to the physician to each supporter. Drive away non-conflicted faculty

PPSA 2009 Collection of Medicare Billing Number For CME events and activities this could be considered a problem due to identity theft Physicians don’t know this number or readily give this out

PPSA 2009 Payment Application If the payment or other transfer of value is related to marketing, education, or research specific to a covered drug, device, biological, or medical supply, the name of that covered drug, device, biological, or medical supply. Question: CME is not brand or device specific, and the language directly references education what is this meant to capture?

PPSA 2009 Effect on Exhibits at National Meetings Reporting cumulative payments of $100 – Negative effect on convention business – Exhibits would have to keep track of Educational Items Distributed and Value Coffee/Tea stations at exhibits (would have to swipe your card for coffee) Will reduce overall traffic to exhibit (physicians hesitant from giving their information just because they visited an exhibit hall)

Changes to Report Physicians but not Manufactures can change report No resolution for physicians to change prior to the publishing of the report.

Pre-Emption No Pre-emption of additional requirements Without some type of true pre-emption, states will be able to pass additional restrictions (this could become a never ending process)

American Academy of Family Physicians Goals Minimizes the administrative burden that reporting requirements would place on physicians; Enables the physician to correct incorrect reporting data before the companies releases it for publication; and Ensures the reporting requirements do not have a chilling effect on efforts to educate physicians about research and new developments in diagnosis and treatment.

For More Information Thomas Sullivan, Rockpointe and John Kamp, Coalition for Healthcare Communication